Although HuR aberrant or over-expression has been reported in a wide range of other cancer types, including ovarian [19], gastric [20], colon [21], and lung [11] adenocarcinoma, very limited information is available regarding HuR expression in endometrial adenocarcinoma [12]. This evidence concerns the gene ELAVL1 and endometrium adenocarcinoma.